摘要
The aim of this study was to assess the efficacy of the combination of endoscopic variceal ligation(EVL)and partial splenic embolization(PSE)compared with EVL alone in cirrhosis patients with thrombocytopenia.In a prospective study,84 cirrhosis patients with esophageal varices and thrombocytopenia(platelet count < 50,000/mm3)underwent EVL plus PSE(N = 42)or EVL alone(N = 42).Primary end points assessed during the follow-up period included the recurrence of varices,progression to variceal bleeding,and death.Comparison between combined treatment and variceal ligation alone by multivariate analysis showed a hazard ratio of 0.44 for the recurrence of varices(P = 0.02),0.19 for progression to variceal bleeding(P = 0.01),and 0.31 for death(P = 0.04).These results suggest that the combination of EVL plus PSE can prevent the recurrence of varices,progression to variceal bleeding,and death in cirrhosis patients with esophageal varices and thrombocytopenia.
The aim of this study was to assess the efficacy of the combination of endoscopic variceal ligation （EVL） and partial splenic embolization （PSE） compared with EVL alone in cirrhosis patients with thrombocytopenia. In a prospective study, 84 cirrhosis patients with esophageal varices and thrombocytopenia （platelet count 〈 50, 000/mm^3） underwent EVL plus PSE （N = 42） or EVL alone （N = 42）. Primary end points assessed during the follow-up period included the recurrence of varices, progression to variceal bleeding, and death. Comparison between combined treatment and variceal ligation alone by multivariate analysis showed a hazard ratio of 0. 44 for the recurrence of varices （P = 0. 02）, 0. 19 for progression to variceal bleeding （P = 0.01）, and 0.31 for death （P = 0.04）. These results suggest that the combination of EVL plus PSE can prevent the recurrence of varices, progression to variceal bleeding, and death in cirrhosis patients with esophageal varices and thrombocytopenia.
